Form 4: BHC Director Roberts Acquires Shares via RSU Award

Bausch Health Companies Inc. director Eiry Roberts received an award of restricted share units valued at $250,000, which will vest prior to the next annual shareholder meeting.

Summary

• Eiry Roberts, a Director at Bausch Health Companies Inc. (BHC), acquired 45,871 common shares through an award of restricted share units (RSUs).
• The RSUs were granted on May 22, 2026, with a grant date value of $250,000.
• These RSUs are set to vest on the day before the Issuer's next Annual Meeting of Shareholders.
• The RSUs will be settled in common shares of the company.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents a standard RSU award to a director, indicating ongoing compensation and alignment, but does not contain new operational or financial performance data.

Positives

• Director Eiry Roberts has received a significant RSU award, indicating continued alignment with shareholder interests.
• The award of $250,000 in RSUs suggests confidence in the company's future prospects by the board.
• The vesting schedule aligns with the company's annual meeting cycle, promoting long-term commitment.

Risks

• The value of the RSUs is subject to the future market price of Bausch Health Companies Inc. common shares.
• Vesting is contingent on remaining a director until the next annual meeting, implying potential risk if the director departs before then.

Future Outlook

The RSUs are scheduled to vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, at which point they will be settled in common shares.

Industry Context

StockSavvy.ai notes that RSU awards to directors are a common practice in the pharmaceutical and healthcare industry to incentivize long-term performance and align executive interests with shareholders. This award to a director of Bausch Health Companies Inc. is consistent with industry norms for board compensation.

Stakeholder Impact

• Shareholders: The RSU award represents a dilution of existing shares, though it is a standard compensation practice intended to align director interests with long-term shareholder value.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• Vesting of RSUs on the date immediately preceding the Issuer's next Annual Meeting of Shareholders.
• Settlement of RSUs in common shares of Bausch Health Companies Inc.

Key Dates

Keywords

Bausch Health Companies Inc., BHC, Form 4, SEC Filing, Director Compensation, Restricted Share Units, RSU Award, Insider Transaction, Equity Award